CCL2 and metabolic dysfunction-associated steatohepatitis: We further predicted potential drugs related to the hub genes in patients with MASH and hepatitis C. The results of molecular docking showed a good binding activity between the two most important components (Budesonide and Dinoprostone) and the two important target proteins (CCL2 and STAT1), and the main forms of interaction between components and targets are electrostatic and van der Waals force.